Drugs.com

JULY 27, 2024

SATURDAY, July 27, 2024 -- As scorching temperatures continue to plague the United States this summer, millions of Americans are at risk for dehydration and heat-linked illness.But what about their medications? Can rising temperatures render those.

105

105

Drug Patent Watch

JULY 27, 2024

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

Drugs 52

Drugs Marketing 52

Perficient: Drug Development

JULY 27, 2024

Welcome to the next installment in our UX in Universal Design series! This edition focuses on the key principles of usability for keyboard access specifically tailored for individuals with physical disabilities within health systems. Ensuring that healthcare digital interfaces are accessible via keyboard navigation is crucial for providing equitable care and improving patient outcomes.

Hospitals 52

Hospitals 52

Drug Patent Watch

JULY 27, 2024

Annual Drug Patent Expirations for NASCOBAL Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is included in two NDAs. It is available from one supplier.

Drugs 52

Drugs Marketing 52

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Perficient: Drug Development

JULY 27, 2024

Welcome to another installment in our UX in Universal Design series! This edition focuses on the key principles of usability for voice control and speech recognition specifically tailored for individuals with physical disabilities within health systems. Voice control and speech recognition technologies are essential tools for enhancing accessibility and improving patient experiences.

Hospitals 52

Hospitals Laboratories 52

Drug Patent Watch

JULY 27, 2024

ALOXI (palonosetron hydrochloride) Helsinn hlthcare Patent: 7,947,725 Expiration: Jul 30, 2024 See More … For more information on how DrugPatentWatch […] Source

Drugs 52

Drugs 52

Drug Patent Watch

JULY 27, 2024

This chart shows the pharmaceutical companies with the most patents in South Africa. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Drugs 52